The pharmaceutical sector continues to transform under the influence of advanced technologies, notably Artificial Intelligence (AI) and connected devices. The emergence of AI, as illustrated by the tool 'id. genius', promises to redefine current paradigms, although concrete details about its features remain unclear. This technological transformation, although innovative, presents significant regulatory and operational challenges. SMEs must navigate this rapidly evolving environment with caution to capitalize on these opportunities while minimizing risks.
Débloquez l'Analyse Complète
Accédez instantanément à nos insights exclusifs générés par IA, basés sur l'agrégation de centaines de sources sectorielles.
